THE SAFETY AND EFFICACY OF BLEOMYCIN, ETOPOSIDE AND CISPLATIN (BEP) CHEMOTHERAPY IN PATIENTS WITH MALIGNANT OVARIAN GERM CELL TUMOR

被引：0
|
作者：
Lee, G. W. [1 ]
Lee, S. W. [1 ]
Park, J. Y. [1 ]
Kim, D. Y. [1 ]
Suh, D. S. [1 ]
Kim, J. H. [1 ]
Kim, Y. M. [1 ]
Kim, Y. T. [1 ]
Nam, J. H. [1 ]
机构：
[1] Asan Med Ctr, Obstet & Gynecol, Seoul, South Korea
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2017年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ESGO7-0778
引用
收藏
页码：1620 / 1620
页数：1
相关论文
共 50 条
  • [1] The safety and efficacy of bleomycin, etoposide and cisplatin (BEP) chemotherapy in patients with malignant ovarian germ cell tumor
    Lee, G. W.
    Park, J. Y.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 94 - 95
  • [2] The safety and efficacy of bleomycin, etoposide and cisplatin (BEP) chemotherapy in patients with malignant ovarian germ cell tumor
    Park, J. Y.
    Kim, D. Y.
    Suh, D. S.
    Kim, J. H.
    Kim, Y. M.
    Kim, Y. T.
    Nam, J. H.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 803 - 803
  • [3] THE SAFETY AND EFFICACY OF BLEOMYCIN, ETOPOSIDE AND CISPLATIN (BEP) CHEMOTHERAPY IN PATIENTS WITH MALIGNANT OVARIAN GERM CELL TUMOR
    Lee, G. W.
    Lee, S. W.
    Park, J. Y.
    Kim, D. Y.
    Suh, D. S.
    Kim, J. H.
    Kim, Y. M.
    Kim, Y. T.
    Nam, J. H.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 320 - 320
  • [4] The safety and efficacy of bleomycin, etoposide and cisplatin (BEP) chemotherapy in patients with malignant ovarian germ cell tumor
    Lee, G.
    Park, J. Y.
    Kim, D. Y.
    Suh, D. S.
    Kim, J. H.
    Kim, Y. M.
    Kim, Y. T.
    Nam, J. H.
    EUROPEAN JOURNAL OF CANCER, 2017, 72 : S96 - S96
  • [5] Combination of bleomycin, etoposide and cisplatin (BEP) versus etoposide and cisplatin (EP) in patients with good risk nonseminomatous germ cell tumors (NSGCT)
    Tryakin, A.
    Fedyanin, M.
    Bulanov, A.
    Titov, D.
    Mitin, A.
    Sergeev, J.
    Figurin, K.
    Fainstein, I.
    Matveev, V.
    Zakharova, T.
    Kostjakova, L.
    Garin, A.
    Tjulandin, S.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S515 - S515
  • [6] Lung function in germ cell cancer (GCC) patients treated with bleomycin-etoposide-cisplatin (BEP)
    Lauritsen, J.
    Kier, M. G. G.
    Bandak, M.
    Mortensen, M. S.
    Thomsen, F. B.
    Daugaard, G.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S517 - S518
  • [7] Antiemetic Efficacy and Safety of Palonosetron on Days 1 and 5 with Aprepitant and Dexamethasone during Bleomycin, Etoposide, and Cisplatin Chemotherapy in Patients with Germ Cell Tumor: A Prospective Study
    Fukuta, Fumimasa
    Kitamura, Hiroshi
    Hotta, Hiroshi
    Itoh, Naoki
    Okada, Manabu
    Shindo, Tetsuya
    Kyoda, Yuki
    Hashimoto, Kohei
    Kobayashi, Ko
    Tanaka, Toshiaki
    Masumori, Naoya
    EUROPEAN JOURNAL OF CANCER CARE, 2024, 2024
  • [8] THE TREATMENT OF METASTATIC GERM-CELL TESTICULAR-TUMORS WITH BLEOMYCIN, ETOPOSIDE AND CISPLATIN (BEP)
    PECKHAM, MJ
    BARRETT, A
    LIEW, KH
    HORWICH, A
    ROBINSON, B
    DOBBS, HJ
    MCELWAIN, TJ
    HENDRY, WF
    BRITISH JOURNAL OF CANCER, 1983, 47 (05) : 613 - 619
  • [9] ETOPOSIDE COMBINATION CHEMOTHERAPY IN REFRACTORY OVARIAN MALIGNANT GERM-CELL TUMOR
    WONG, LC
    COLLINS, RJ
    NGAN, HYS
    MA, HK
    GYNECOLOGIC ONCOLOGY, 1990, 39 (02) : 123 - 126
  • [10] Survival and reproductive function of 52 women treated with surgery and bleomycin, etoposide, cisplatin (BEP) chemotherapy for ovarian yolk sac tumor
    Rouge, T. de la Motte
    Pautier, P.
    Duvillard, P.
    Rey, A.
    Morice, P.
    Haie-Meder, C.
    Kerbrat, P.
    Culine, S.
    Troalen, F.
    Lhomme, C.
    ANNALS OF ONCOLOGY, 2008, 19 (08) : 1435 - 1441
12345